Bicara Therapeutics. Every tracked FinTwit mention of $BCAX, newest first. 5 mentions since the first on Sep 29, 2025. See the price chart.
February 2026 · 2 mentions
Feb 23
Jacob Plieth — $BCAX took 1.5g weekly into ph3, but now says 2g Q2W is better, reducing frequency & maintaining efficacy.
But that's not even the final dose! That's Q3W, which they've not eve…↗
Feb 23
Jacob Plieth — Why is $BCAX testing a ficera dose in phase 3 that it now says isn't optimal (and other uncomfortable questions)? Via @ApexOnco -> https://t.co/mLWKP6AAZ9 $JNJ $GMAB↗
September 2025 · 3 mentions
Sep 29
Jacob Plieth — Petosemtamab delivers a buyout for $MRUS. @ApexOnco take on the $8bn acquisition by $GMAB https://t.co/KqNb9vt7pI $BCAX↗
Sep 29
Jacob Plieth — The argument that this or that biotech has been "oversold" has again been shown to be bogus. Biopharma will absolutely pay top dollar for what it deems to be the best asset $BCAX $…↗
Sep 29
Jacob Plieth — With $GMAB buying $MRUS it looks like $BCAX is playing the role of $STRO in Profoundbio.↗